Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions Hannah GoulartJohn MascarenhasDouglas Tremblay Review Article 28 March 2022 Pages: 935 - 951
Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis Huifeng ZhouJunjie FanShaoyan Hu Original Article 12 February 2022 Pages: 953 - 961
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives Nicola VianelliGiuseppe AuteriFrancesca Palandri Original Article 24 February 2022 Pages: 963 - 978
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma Kayoko MurayamaToru KiguchiYasuhito Terui Original Article Open access 04 March 2022 Pages: 979 - 989
Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon Peter NounAdlette InatiHassan Khalife Original Article 12 March 2022 Pages: 991 - 997
The spectrum of paroxysmal nocturnal hemoglobinuria clinical presentation in a Brazilian single referral center Bruno G. P. Pires da SilvaNatasha P. FonsecaRodrigo T. Calado Original Article Open access 18 February 2022 Pages: 999 - 1007
Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease Maria PoplawskaDibyendu DuttaSeah H. Lim Original Article 15 February 2022 Pages: 1009 - 1013
Discontinuation of tyrosine kinase inhibitor in chronic myeloid leukemia: a retrospective cohort in east occitania J. B. RobinA. TheronG. Cartron Original Article 12 March 2022 Pages: 1015 - 1022
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Eugene BrailovskiQing LiLee Mozessohn Original Article 22 February 2022 Pages: 1023 - 1030
Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis A. BoquoiS. M. BanahanR. Fenk Original Article Open access 09 March 2022 Pages: 1031 - 1038
Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide Yuan WangWenyi HouYingmei Zhang Original Article 16 February 2022 Pages: 1039 - 1047
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study Mehmet BaysalVildan GürsoyRidvan Ali Original Article 21 February 2022 Pages: 1049 - 1057
Improved survival of Burkitt lymphoma/leukemia patients: observations from Poland, 1999–2020 Florentino Luciano Caetano dos SantosIrmina Maria MichalekJan Walewski Original Article 15 March 2022 Pages: 1059 - 1065
CD37 expression in follicular lymphoma Takuro YoshimuraHiroaki MiyoshiKoichi Ohshima Original Article 16 February 2022 Pages: 1067 - 1075
A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma Trine HusbyHåkon JohansenLive Eikenes Original Article Open access 16 February 2022 Pages: 1077 - 1088
Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine David J. HermelBrian ChengAlan Saven Original Article 26 February 2022 Pages: 1089 - 1096
Real-world outcomes in elderly ALL patients with and without allogeneic hematopoietic stem cell transplantation: a single-center evaluation over 10 years Kevin D. HoferUrs SchanzCorinne C. Widmer Original Article Open access 19 February 2022 Pages: 1097 - 1106
Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection Hanna A. KnausW. RabitschP. Wohlfarth Letter to the Editor 13 October 2021 Pages: 1107 - 1110
Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination Ali AtouiKawthar JarrahAli T. Taher Letter to the Editor 27 January 2022 Pages: 1111 - 1113
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey Eriko HamadaKazuya SakaiMasanori Matsumoto Letter to the Editor 04 February 2022 Pages: 1115 - 1117
Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis Marko LucijanicMartina DemariaTatjana Keres Letter to the Editor 11 March 2022 Pages: 1119 - 1121
ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis Yen-Ching WangTsung-Chih ChenCheng-Han Wu Letter to the Editor 18 October 2021 Pages: 1123 - 1124
VEXAS-like syndrome: a potential new entity? Andrea DuminucoCalogero VetroGiuseppe A. M. Palumbo Letter to the Editor 22 March 2022 Pages: 1125 - 1128
Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA Suguru MorimotoTadakazu KondoAkifumi Takaori-Kondo Letter to the Editor 26 March 2022 Pages: 1129 - 1132
Bone marrow necrosis as complication of treatment with all-trans retinoic acid and arsenic trioxide: case report and implications for treatment Carin L. E. HazenbergArjan DiepstraEmanuele Ammatuna Letter to the Editor 08 November 2021 Pages: 1133 - 1134
Degenerated mitochondria in leukemic blast appeared as granules on May-Grunwald-Giemsa staining Hirofumi TakanoMegumi YasunagaMineo Kurokawa Letter to the Editor 18 October 2021 Pages: 1135 - 1136
Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia Kelsey UminskiRoy KhalifeAlan Tinmouth Letter to the Editor 06 October 2021 Pages: 1137 - 1139
The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia Yi ZhangJie-Jing QianHong-Hu Zhu Letter to the Editor 18 October 2021 Pages: 1141 - 1144
Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy Rory M. ShallisDarko PucarAmer M. Zeidan Letter to the Editor 22 October 2021 Pages: 1145 - 1147
Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma Eric TseRex Au-YeungYok-Lam Kwong Letter to the Editor 10 November 2021 Pages: 1149 - 1152
Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report Michiaki SatoMegumi YasunagaMineo Kurokawa Letter to the Editor 02 December 2021 Pages: 1153 - 1155
Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses Chisako IriyamaKenichiro MurateAkihiro Tomita Letter to the Editor Open access 02 October 2021 Pages: 1157 - 1159
Correction to: Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses Chisako IriyamaKenichiro MurateAkihiro Tomita Correction 27 November 2021 Pages: 1161 - 1162
